Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Prostatic Neoplasms 5Breast Neoplasms 5Sarcoma 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Carcinoma, Renal Cell 3Wilms Tumor 2Unspecified Adult Solid Tumor, Protocol Specific 2Testicular Neoplasms 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Kidney Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Burkitt Lymphoma 2Breast Neoplasms, Male 2Astrocytoma 2

Interventions

Cetuximab 7Magnetic Resonance Spectroscopy 5Radiotherapy 4Erlotinib Hydrochloride 4Cisplatin 4Bevacizumab 4Trastuzumab 3Specimen Handling 3Radiotherapy, Conformal 3Carboplatin 3sargramostim 2ixabepilone 2Vorinostat 2Sorafenib 2SS1(dsFv)PE38 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Paclitaxel 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Lapatinib 2Fluorouracil 2Fluorodeoxyglucose F18 2Docetaxel 2Dasatinib 2Chemotherapy, Adjuvant 2Biopsy 2trastuzumab deruxtecan 1tipifarnib 1temsirolimus 1temoporfin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Salivary Gland Neoplasms × ixabepilone × Clear all
NCT00033618 2013-02-27

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

National Cancer Institute (NCI)

Phase 2 Completed
144 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00057850 2013-02-11

BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1/2 Completed
27 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡